A Decentralized Clinical Study Evaluating the Effectiveness of Two Different Doses of MyCondro™ on Physical Mobility and Joint Health

Exclusion criteria

• ✕. Use of a Chondroitin Sulfate supplement in the 3 months prior to randomization.
• ✕. Current use of other joint health supplements (e.g., glucosamine, hyaluronic acid, collagen peptides) for at least 4 weeks prior to randomization.
• ✕. Use of any intra-articular or intravenous steroid injections in the last 3 months.
• ✕. Receiving any investigational therapies or treatments within 30 days prior to randomization.
• ✕. Self-reported inflammatory arthropathies, such as Rheumatoid Arthritis, Gout, and Infectious Arthritis.
• ✕. Significant systemic lung, liver, heart, or kidney disease (excluding hypertension).
• ✕. Prior history of knee surgery within 3 months preceding the study period, or planned knee surgery (including arthroscopy) during the study period.
• ✕. Currently diagnosed with Alcohol Use Disorder and/or Substance Use Disorder.